Avita Medical (RCEL) Stock Price, News & Analysis

Company Overview

AVITA Medical, Inc. is a regenerative medicine company focused on developing and commercializing treatments that use a patient’s own skin cells to support the healing of wounds and tissue defects. Its primary product is the RECELL Autologous Cell Harvesting Device, which enables clinicians to prepare a suspension of a patient’s skin cells at the point of care for application to damaged areas.

RECELL is designed to assist with the treatment of thermal burn wounds and certain full-thickness skin defects. The technology is intended to expand the use of a small skin sample, potentially reducing the amount of donor skin required for wound coverage. AVITA Medical markets RECELL primarily to hospitals, burn centers and other healthcare providers.

The company has roots in Australia and has developed its business with a strong focus on the U.S. healthcare market. RECELL received U.S. Food and Drug Administration approval for use in burn care and later gained expanded authorization for certain full-thickness skin defects. AVITA Medical is headquartered in Valencia, California, and its operations are focused on advancing and commercializing regenerative wound-care technologies.

Key Stats

• Today's Range: $12.02 to $12.76
• 50-Day Range: $4.40 to $12.72
• 52-Week Range: $3.22 to $12.76
• Volume: 391,166 shs
• Average Volume: 286,326 shs
• Market Capitalization: $391.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $11.40
• Consensus Rating: Moderate Buy

Avita Medical Stock Analysis - MarketRank™

Avita Medical scored higher than 22% of companies evaluated by MarketBeat, and ranked 790th out of 888 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Avita Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.57, and is based on no strong buy ratings, 5 buy ratings, 1 hold rating, and 1 sell rating.

Downside Risk

Avita Medical has a consensus price target of $11.40, representing about 10.4% downside from its current price of $12.72.

Amount of Analyst Coverage

Avita Medical has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Avita Medical are expected to grow in the coming year, from ($0.98) to ($0.52) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Avita Medical is -8.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Avita Medical is -8.83, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

9.59% of the float of Avita Medical has been sold short.

Short Interest Ratio / Days to Cover

Avita Medical has a short interest ratio ("days to cover") of 10.54, which indicates bearish sentiment.

Change versus previous month

Short interest in Avita Medical has recently decreased by 1.78%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Avita Medical does not currently pay a dividend.

Dividend Growth

Avita Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 1.25

News Sentiment

Avita Medical has a news sentiment score of 1.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Avita Medical this week, compared to 3 articles on an average week.

MarketBeat Follows

Only 2 people have added Avita Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Avita Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.24% of the stock of Avita Medical is held by insiders.

Percentage Held by Institutions

27.66% of the stock of Avita Medical is held by institutions.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/02/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NASDAQ:RCEL
• CIK: 1762303
• Web: www.avitamedical.com
• Phone: (833) 462-8482
• Fax: N/A
• Employees: 226
• Year Founded: 1992

Price Target and Rating

• Average Price Target for Avita Medical: $11.40
• High Price Target: $14.00
• Low Price Target: $10.00
• Potential Upside/Downside: -10.4%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.57
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.44)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$48.59 million
• Net Margins: -56.96%
• Pretax Margin: -56.94%
• Return on Equity: N/A
• Return on Assets: -78.53%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.41
• Quick Ratio: 0.34

Sales & Book Value

• Annual Sales: $71.61 million
• Price / Sales: 5.47
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.55) per share
• Price / Book: -23.13

Miscellaneous

• Outstanding Shares: 30,780,000
• Free Float: 30,088,000
• Market Cap: $391.52 million
• Optionable: Optionable
• Beta: 1.99